°ÄÃÅÁùºÏ²Ê¿ª½±app

Scott L. Weiss, MD

Critical Care

Primary Office

°ÄÃÅÁùºÏ²Ê¿ª½±app's Hospital, Delaware °ÄÃÅÁùºÏ²Ê¿ª½±app's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803 Appointment: (800) 416-4441

Get to Know Me

Scott L. Weiss, MD MSCE FCCM is an associate professor of pediatrics at Thomas Jefferson University and division chief of critical care medicine at °ÄÃÅÁùºÏ²Ê¿ª½±app Hospital. Previously, Dr. Weiss was on the faculty at the Children’s Hospital of Philadelphia, where he earned recognition as an international expert in pediatric sepsis.  Dr. Weiss’ NIH-funded research focuses on epidemiology, fluid resuscitation and mitochondrial dysfunction in pediatric sepsis.

Why I Treat Children

Medicine offers a rare opportunity to engage with an individual at a vulnerable point of suffering from illness or injury, especially in critical care. I wear this as a badge of humility and respect for our patients and families. When the patient is a child, the trust offered by a family is particularly noteworthy and opportunity to support health and well-being is particularly impactful. I am also constantly amazed that, despite not feeling their best, children look to play, smile and enjoy life rather than seeing themselves as patients.  In the intensive care unit, I am inspired every day by the children and their families, which drives me to provide the best care possible.

What I'm Passionate About

My clinical focus is on children with sepsis, which is a medical emergency of life-threatening organ failure caused by a severe infection. I have been privileged to work with local, national and international teams to optimize systems and methods to recognize and treat sepsis in children to reduce negative impacts that this illness can have on families.

How I Try to Make A Difference

In addition to my clinical responsibilities in the pediatric ICU, I work as a scientist studying mechanisms of organ failure during sepsis. In particular, I focus on the role of mitochondria in sepsis. Mitochondria are the parts of our cells that produce the energy our body needs to stay healthy. My research seeks to understand how sepsis damages mitochondria, in order to develop new therapies that will promote recovery from sepsis-induced organ failure.

Education & Training

Fellowship

  • Pediatric Critical Care Med - McGaw Medical Center of Northwestern University, 2011

Internship Residency

  • General Pediatrics - Boston Childrens Hospital/Boston Medical Center, 2007

Medical/Dental School

  • MD - Harvard Medical School, 2004

Board Certifications

  • American Board of Pediatrics/Pediatric Critical Care
  • American Board of Pediatrics/General Pediatrics

Awards & Recognition

  • 2022 Top Ten Reviewer, Pediatric Research
  • 2022 Presidential Citation, Society of Critical Care Medicine
  • 2021 Star Research Achievement Award, Society of Critical Care Medicine Annual Congress, Orlando, FL
  • 2021 Presidential Citation, Society of Critical Care Medicine
  • 2020 Star Research Achievement Award, Society of Critical Care Medicine Annual Congress, Orlando, FL
  • 2020 Presidential Citation, Society of Critical Care Medicine
  • 2019 Presidential Citation, Society of Critical Care Medicine
  • 2018 Pediatric Section Travel Grant Award, Society of Critical Care Medicine Annual Congress, San Antonio, TX
  • 2018 Presidential Citation, Society of Critical Care Medicine
  • 2017 Fellow of Critical Care Medicine (FCCM), Society of Critical Care Medicine
  • 2017 Editor’s commendation for authorship in Emergency Medicine, UpToDate
  • 2017 Presidential Citation, Society of Critical Care Medicine
  • 2017 Pediatric Section Travel Grant Award, Society of Critical Care Medicine Annual Congress, Honolulu, HI
  • 2017 Star Research Achievement Award, Society of Critical Care Medicine Annual Congress, Honolulu, HI
  • 2015 Patient-Oriented Research Track Award, CHOP Research Poster Day, Philadelphia, PA
  • 2014 Sepsis Specialty Research Award, Society of Critical Care Medicine Annual Congress, San Francisco, CA
  • 2010 Pediatric Critical Care Colloquium Research Award, Pittsburgh, PA

Insurance Accepted

  • Aetna Better Health PA Kids HMO
  • Aetna HMO
  • Aetna PPO/POS/EPO
  • Amerihealth Caritas Delaware
  • Carefirst MD Community Health Plan Mcaid
  • Cigna Lifesource Transplant
  • Cigna/Great West HMO EPO POS
  • Cigna/Great West PPO
  • Delaware First Health
  • Delaware Medicaid/Diamond State
  • Devon Health Services
  • Fidelis Care NJ Medicaid HMO
  • First Health/Affordable PPO
  • Geisinger Health Plan Commercial
  • Health Partners Medicaid/Kidz Partner HMO
  • Highmark Blue Cross Blue Shield of Delaware
  • Highmark Medicaid Health Options
  • Horizon Blue Cross Blue Shield of New Jersey
  • Independance Blue Cross/Amerihealth/Keystone Health Plan
  • Insurance Administrators of America
  • INTEGRA Administrative Group (ClaimsBridge)
  • Keystone First Medicaid HMO
  • Lifetrac Transplant
  • Maryland Medicaid
  • Multiplan PPO
  • National Transplant (Humana)
  • New Jersey Medicaid
  • Olympus Managed Healthcare PPO DE/PA
  • Pennsylvania Medicaid
  • Preferred Healthcare PPO
  • Private Health Care Systems (PHCS)
  • Qualcare HMO/POS/PPO
  • Star Healthcare Network
  • Three Rivers Provider Network
  • Tricare/Humana Military Health Services/CHAMPVA
  • United Healthcare of the Mid-Atlantic
  • UPMC MCAID/CHIP PA DE
  • US Family Health Plan
  • Wellpoint Maryland Medcaid

Research Activities

  • Mitochondrial Dysfunction in Pediatric Sepsis
  • Effect of Mitochondrial Quality Control on Systemic Inflammation and Organ Dysfunction in Pediatric Sepsis
  • PRagMatic Pediatric Trial of Balanced versus NOrmaL Saline FlUid in Sepsis (PRoMPT BOLUS international, multicenter randomized clinical trial)
  • Genotype Variation Underlying Pediatric Sepsis Sub-phenotypes
  • Readmissions After Pediatric Sepsis

Medical Interests

  • Sepsis
  • Multiple organ dysfunction syndrome (MODS)
  • Immunometabolism
  • Fluid resuscitation
  • Epidemiology & patient outcomes

  • Is hyperchloremia following sepsis resuscitation with 0.9% saline clin-ically important?; Critical Care and Shock; (2021).

  • What's the Cost? Measuring the Economic Impact of Pediatric Sepsis; Frontiers in Pediatrics; (2021).

  • Recalibration of the Renal Angina Index for Pediatric Septic Shock; Kidney International Reports; (2021).

  • PRagMatic Pediatric Trial of Balanced vs nOrmaL Saline FlUid in Sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial; Trials; (2021).

  • Let Us Not Forget Early Mortality in Pediatric Sepsis; Pediatric Critical Care Medicine; (2021).

  • Left Ventricular Diastolic Dysfunction in Pediatric Sepsis: Outcomes in a Single-Center Retrospective Cohort Study; Pediatric Critical Care Medicine; (2021).

  • Integrating Focused Cardiac Ultrasound into Pediatric Septic Shock Assessment; Pediatric Critical Care Medicine; (2021).

  • Implementation of a Follow-Up System for Pediatric Sepsis Survivors in a Large Academic Pediatric Intensive Care Unit; Frontiers in Pediatrics; (2021).

  • Impaired lymphocyte responses in pediatric sepsis vary by pathogen type; medRxiv; (2021).

  • Association of early hypotension in pediatric sepsis with development of new or persistent acute kidney injury; Pediatric Nephrology; (2021).

  • A Wrinkle in Time to Antibiotics in Sepsis: When Should ONE Hour Be the Goal?; Journal of Pediatrics; (2021).

  • A Stitch in Time: Optimizing Antibiotic Use From the Start; Critical care medicine; (2021).

  • Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children; Pediatric Critical Care Medicine; (2020).

  • The authors reply; Pediatric Critical Care Medicine; (2020).

  • The authors reply; Pediatric Critical Care Medicine; (2020).

  • The authors reply; Pediatric Critical Care Medicine; (2020).

  • The authors reply; Pediatric Critical Care Medicine; (2020).

  • Utility of Procalcitonin as a Biomarker for Sepsis in Children; Journal of Clinical Microbiology; (2020).

  • Severe acute kidney injury is independently associated with mortality in children with septic shock; Intensive Care Medicine; (2020).

  • Clinical Signs to Categorize Shock and Target Vasoactive Medications in Warm Versus Cold Pediatric Septic Shock; Pediatric Critical Care Medicine; (2020).

  • Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children; Blood Advances; (2020).

  • Diaphragm atrophy during pediatric acute respiratory failure is associated with prolonged noninvasive ventilation requirement following extubation; Pediatric Critical Care Medicine; (2020).

  • Executive summary: Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children; Pediatric Critical Care Medicine; (2020).

  • Risk of Mortality in Immunocompromised Children with Severe Sepsis and Septic Shock; Critical Care Medicine; (2020).

  • Reactivation viremia in pediatric sepsis; Pediatric Critical Care Medicine; (2020).

  • RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness; Journal of Allergy and Clinical Immunology; (2020).

  • Publisher Correction: Exuberant fibroblast activity compromises lung function via ADAMTS4 (Nature, (2020), 587, 7834, (466-471), 10.1038/s41586-020-2877-5); Nature; (2020).

  • Proprotein convertase subtilisin/kexin type 9 loss-of-function is detrimental to the juvenile host with septic shock; Critical Care Medicine; (2020).

  • Perspective of the Surviving Sepsis Campaign on the Management of Pediatric Sepsis in the Era of Coronavirus Disease 2019; Pediatric Critical Care Medicine; (2020).

  • PERSEVERE Biomarkers predict severe acute kidney injury and renal recovery in pediatric septic shock; American Journal of Respiratory and Critical Care Medicine; (2020).

  • Mitochondrial Dysfunction is Associated With an Immune Paralysis Phenotype in Pediatric Sepsis; Shock (Augusta, Ga.); (2020).

  • Might the surviving sepsis campaign international guidelines be less confusing? Authors' reply; Intensive Care Medicine; (2020).

  • Ketamine Use for Tracheal Intubation in Critically Ill Children Is Associated with a Lower Occurrence of Adverse Hemodynamic Events; Critical Care Medicine; (2020).

  • Identification of pediatric sepsis for epidemiologic surveillance using electronic clinical data; Pediatric Critical Care Medicine; (2020).

  • Exuberant fibroblast activity compromises lung function via ADAMTS4; Nature; (2020).

  • Executive summary: surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children; Intensive Care Medicine; (2020).

  • Surviving Sepsis in a Referral Neonatal Intensive Care Unit: Association between Time to Antibiotic Administration and In-Hospital Outcomes; Journal of Pediatrics; (2020).

  • Association between elevated RBC distribution width and multiple organ dysfunction in pediatric critical illness; Pediatric Critical Care Medicine; (2020).

  • Systemic endothelial activation is associated with early acute respiratory distress syndrome in children with extrapulmonary sepsis; Critical Care Medicine; (2020).

  • Clinical Update in Pediatric Sepsis: Focus on Children With Pre-Existing Heart Disease; Journal of Cardiothoracic and Vascular Anesthesia; (2020).

  • Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children; Intensive Care Medicine; (2020).

  • Vancomycin monotherapy may be insufficient to treat methicillin-resistant staphylococcus aureus coinfection in children with influenza-related critical illness; Clinical Infectious Diseases; (2019).

  • Risks and benefits of fluid bolus therapy: The need for a good explanation; Archives of Disease in Childhood; (2019).

  • Evaluation of mannose binding lectin gene variants in pediatric influenza virus-related critical illness; Frontiers in Immunology; (2019).

  • Neonatal sepsis registry: Time to antibiotic dataset; Data in Brief; (2019).

  • Matched Retrospective Cohort Study of Thiamine to Treat Persistent Hyperlactatemia in Pediatric Septic Shock; Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies; (2019).

  • Major adverse kidney events in pediatric sepsis; Clinical Journal of the American Society of Nephrology; (2019).

  • Is chloride worth its salt?; Intensive Care Medicine; (2019).

  • Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: The Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study; Journal of the Pediatric Infectious Diseases Society; (2019).

  • Comparison of Methods for Identification of Pediatric Severe Sepsis and Septic Shock in the Virtual Pediatric Systems Database; Critical care medicine; (2019).

  • A national approach to pediatric sepsis surveillance; Pediatrics; (2019).

  • Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis: The PRoMPT BOLUS Randomized Controlled Trial Pilot Feasibility Study; Academic Emergency Medicine; (2019).

  • Persistent Mitochondrial Dysfunction Linked to Prolonged Organ Dysfunction in Pediatric Sepsis; Critical care medicine; (2019).

  • Risk Factors for Mortality in Pediatric Postsurgical versus Medical Severe Sepsis; Journal of Surgical Research; (2019).

  • Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model; Science Translational Medicine; (2019).

  • Reducing Collateral Damage from Mandates for Time to Antibiotics in Pediatric Sepsis - Primum Non Nocere; JAMA Pediatrics; (2019).

  • Risk factors and inpatient outcomes associated with acute kidney injury at pediatric severe sepsis presentation; Pediatric Nephrology; (2018).

  • Progressive diaphragm atrophy in pediatric acute respiratory failure; Pediatric Critical Care Medicine; (2018).

  • Measuring hospital performance in pediatric sepsis: Without reliable risk there is no reward; Pediatric Critical Care Medicine; (2018).

  • Hypofibrinogenemia is associated with poor outcome and secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome in pediatric severe sepsis; Pediatric Critical Care Medicine; (2018).

  • Hyperchloremia is associated with acute kidney injury in pediatric patients with septic shock; Intensive Care Medicine; (2018).

  • Hyperchloremia Is Associated with Complicated Course and Mortality in Pediatric Patients with Septic Shock; Pediatric Critical Care Medicine; (2018).

  • Focus on paediatrics: 2017; Intensive Care Medicine; (2018).

  • Endotype Transitions During the Acute Phase of Pediatric Septic Shock Reflect Changing Risk and Treatment Response; Critical care medicine; (2018).

  • Effect of the procalcitonin assay on antibiotic use in critically ill children; Journal of the Pediatric Infectious Diseases Society; (2018).

  • Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis; JAMA - Journal of the American Medical Association; (2018).

  • Are septic children really just "septic little adults"?; Intensive Care Medicine; (2018).

  • Site variability in regulatory oversight for an international study of pediatric sepsis; Pediatric Critical Care Medicine; (2018).

  • Taking meaning from numbers in regional epidemiological data; The Lancet Child and Adolescent Health; (2018).

  • The Failing Myocardium in Sepsis; Heart Failure in the Child and Young Adult: From Bench to Bedside; (2018).

  • The association of nutrition status expressed as body mass index z score with outcomes in children with severe sepsis: A secondary analysis from the sepsis prevalence, outcomes, and therapies (SPROUT) study; Critical Care Medicine; (2018).

  • Response to letter to the editor: Sepsis-associated in-hospital cardiac arrest; Journal of Critical Care; (2017).

  • High Levels of Morbidity and Mortality among Pediatric Hematopoietic Cell Transplant Recipients with Severe Sepsis: Insights from the Sepsis PRevalence, OUtcomes, and Therapies International Point Prevalence Study; Pediatric Critical Care Medicine; (2017).

  • The American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock: Executive Summary; Pediatric Critical Care Medicine; (2017).

  • The Epidemiology of Hospital Death Following Pediatric Severe Sepsis: When, Why, and How Children with Sepsis Die; Pediatric Critical Care Medicine; (2017).

  • Glucocorticoid Receptor Polymorphisms and Outcomes in Pediatric Septic Shock; Pediatric Critical Care Medicine; (2017).

  • Recommendations for regulation of screen viewing times in childhood and adolescence: Consensus paper of the working group on sleep medicine and sleep research of the Austrian Society of Pediatrics and Adolescent Medicine,Empfehlungen zur Regulierung von Bildschirmzeiten im Kindes- und Jugendalter: Konsensuspapier der Arbeitsgruppe Schlafmedizin und Schlafforschung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde; Monatsschrift fur Kinderheilkunde; (2017).

  • Pathophysiology of pediatric multiple organ dysfunction syndrome; Pediatric Critical Care Medicine; (2017).

  • New or Progressive Multiple Organ Dysfunction Syndrome in Pediatric Severe Sepsis: A Sepsis Phenotype With Higher Morbidity and Mortality; Pediatric Critical Care Medicine; (2017).

  • Multiple Organ Dysfunction in Children Mechanically Ventilated for Acute Respiratory Failure; Pediatric Critical Care Medicine; (2017).

  • Improving Recognition of Pediatric Severe Sepsis in the Emergency Department: Contributions of a Vital Sign-Based Electronic Alert and Bedside Clinician Identification; Annals of Emergency Medicine; (2017).

  • Improved risk stratification in pediatric septic shock using both protein and mRNA Biomarkers: Persevere-XP; American Journal of Respiratory and Critical Care Medicine; (2017).

  • Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia; Critical Care Medicine; (2017).

  • Sepsis-associated in-hospital cardiac arrest: Epidemiology, pathophysiology, and potential therapies; Journal of Critical Care; (2017).

  • Crystalloid Fluid Choice and Clinical Outcomes in Pediatric Sepsis: A Matched Retrospective Cohort Study; Journal of Pediatrics; (2017).

  • Clinical Trials in Pediatric Sepsis: What's the (End) Point?; Pediatric Critical Care Medicine; (2017).

  • Association of Delayed Antimicrobial Therapy with One-Year Mortality in Pediatric Sepsis; Shock; (2017).

  • American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock; Critical Care Medicine; (2017).

  • A pragmatic biomarker-driven algorithm to guide antibiotic use in the pediatric intensive care unit: The optimizing antibiotic strategies in sepsis (OASIS) study; Journal of the Pediatric Infectious Diseases Society; (2017).

  • The authors reply; Pediatric Critical Care Medicine; (2017).

  • Combining Prognostic and Predictive Enrichment Strategies to Identify Children with Septic Shock Responsive to Corticosteroids; Critical Care Medicine; (2016).

  • Comparison of Pediatric Severe Sepsis Managed in U.S. and European ICUs; Pediatric Critical Care Medicine; (2016).

  • Value of Procalcitonin Measurement for Early Evidence of Severe Bacterial Infections in the Pediatric Intensive Care Unit; Journal of Pediatrics; (2016).

  • Protocolized Treatment Is Associated with Decreased Organ Dysfunction in Pediatric Severe Sepsis; Pediatric Critical Care Medicine; (2016).

  • Pediatric severe sepsis/septic shock associated with healthcare-associated infections; Infection Control and Hospital Epidemiology; (2016).

  • Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model with Septic Shock Phenotype; Critical Care Medicine; (2016).

  • Staphylococcus aureus a-toxin response distinguishes respiratory virus-methicillin-resistant s. aureus coinfection in children; Journal of Infectious Diseases; (2016).

  • Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia; Cancer Discovery; (2016).

  • Impairment of mitochondrial respiration following ex vivo cyanide exposure in peripheral blood mononuclear cells; Clinical Toxicology; (2016).

  • Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid- Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein; PLoS ONE; (2016).

  • Acute Kidney Injury in Pediatric Severe Sepsis: An Independent Risk Factor for Death and New Disability; Critical Care Medicine; (2016).

  • 2016 Update for the Rogers' Textbook of Pediatric Intensive Care: Recognition and Initial Management of Shock; Pediatric Critical Care Medicine; (2016).

  • Hyperferritinemic sepsis: An opportunity for earlier diagnosis and intervention?; Frontiers in Pediatrics; (2016).

  • A multibiomarker-based model for estimating the risk of septic acute kidney injury; Critical Care Medicine; (2015).

  • Developing a clinically feasible personalized medicine approach to pediatric septic shock; American Journal of Respiratory and Critical Care Medicine; (2015).

  • The authors reply; Pediatric Critical Care Medicine; (2015).

  • Red blood cell distribution width as a pragmatic marker for outcome in pediatric critical illness; PLoS ONE; (2015).

  • Mitochondrial dysfunction in peripheral blood mononuclear cells in pediatric septic shock; Pediatric Critical Care Medicine; (2015).

  • Comparison of Two Sepsis Recognition Methods in a Pediatric Emergency Department; Academic Emergency Medicine; (2015).

  • Long-Term Respiratory Support for Children and Adolescents in Austria: A National Survey; Klinische Padiatrie; (2015).

  • Initial resuscitation and management of pediatric septic shock; Minerva pediatrica; (2015).

  • Identifying Pediatric Severe Sepsis and Septic Shock: Accuracy of Diagnosis Codes; The Journal of pediatrics; (2015).

  • Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study; American journal of respiratory and critical care medicine; (2015).

  • Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence study; Critical Care; (2015).

  • Differential expression of the Nrf2-linked genes in pediatric septic shock; Critical Care; (2015).

  • Prospective Testing and Redesign of a Temporal Biomarker Based Risk Model for Patients With Septic Shock: Implications for Septic Shock Biology; EBioMedicine; (2015).

  • Differential expression of the nuclear-encoded mitochondrial transcriptome in pediatric septic shock; Critical Care; (2014).

  • Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis; Critical Care Medicine; (2014).

  • Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock; American Journal of Respiratory and Critical Care Medicine; (2014).

  • Corticosteroids and pediatric septic shock outcomes: A risk stratified analysis; PLoS ONE; (2014).

  • Elevated malondialdehyde levels in sepsis - something to 'stress' about?; Critical Care; (2014).

  • Pediatric severe sepsis in U.S. children's hospitals; Pediatric Critical Care Medicine; (2014).

  • Post-ICU admission fluid balance and pediatric septic shock outcomes: A risk-stratified analysis; Critical Care Medicine; (2014).

  • Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model; PLoS ONE; (2014).

  • Understanding the global epidemiology of pediatric critical illness: The power, pitfalls, and practicalities of point prevalence studies; Pediatric Critical Care Medicine; (2014).

  • The temporal version of the pediatric sepsis biomarker risk model; PLoS ONE; (2014).

  • Can peripheral blood mononuclear cells be used as a proxy for mitochondrial dysfunction in vital organs during hemorrhagic shock and resuscitation?; Shock; (2013).

  • Pilot study of the association of the DDAH2-449G polymorphism with asymmetric dimethylarginine and hemodynamic shock in pediatric sepsis; PLoS ONE; (2012).

  • Evaluation of asymmetric dimethylarginine, arginine, and carnitine metabolism in pediatric sepsis; Pediatric Critical Care Medicine; (2012).

  • Defining pediatric sepsis by different criteria: Discrepancies in populations and implications for clinical practice; Pediatric Critical Care Medicine; (2012).

  • Diagnosis of a craniopharyngioma after acute brainstem herniation in an emergency department; Pediatric Emergency Care; (2011).

  • Comparison of gastrointestinal morbidity after Norwood and hybrid palliation for complex heart defects; Pediatric Cardiology; (2011).

  • Calcified Right Atrial Myxoma in an Adolescent; World Journal for Pediatric and Congenital Heart Surgery; (2011).

  • Extreme stress hyperglycemia during acute illness in a pediatric emergency department; Pediatric Emergency Care; (2010).

  • Procalcitonin levels in febrile infants after recent immunization; Pediatrics; (2008).

  • Procalcitonin in young febrile infants for the detection of Serious bacterial infections; Pediatrics; (2008).

  • Robust coupling of body movement and gaze in young infants; Developmental Psychobiology; (2007).

  • English